Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter

European Journal of Pharmacology

Volumn 318, Issue 2-3, 1996, Pages 477-484

  Halmos, Thérèse ^a   Santarromana, Monique ^b   Antonakis, Kostas ^a   Scherman, Daniel ^b  

^a UMR 133 CNRS/RPR   (France)

^b SANOFI   (France)

Author keywords

Blood brain barrier; Chlorambucil; Erythrocyte; Glucose; GLUT1 transporter

Indexed keywords

CYTOCHALASIN B; GLUCOSE; GLUCOSE TRANSPORTER; GLYCOSIDE;

ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ERYTHROCYTE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, ALKYLATING; BLOOD-BRAIN BARRIER; CHLORAMBUCIL; CYTOCHALASIN B; DRUG CARRIERS; ERYTHROCYTES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030607725     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00796-0     Document Type: Article

References (38)

1. Ahn, Y.S., H. Zerban and P. Bannasch, 1993, Expression of glucose transporter isoforms (GLUT1, GLUT2) and activities of hexokinase, pyruvate kinase, and malic enzyme in preneoplastic and neoplastic rat renal basophilic cell lesions, Virchows Arch. B Cell Pathol. 63, 351.
2. Barnett, J.E.G., G.D. Holman and K.A. Munday, 1973, Structural requirements for the binding to the sugar-transport system of the human erythrocyte, Biochem. J. 131,211.
3. Barnett, J.E.G., G.D. Holman, R.A. Chalkley and K.A. Munday, 1975, Evidence for two asymmetric conformational states in the human erythrocyte sugar-transport system, Biochem. J. 145, 417.
4. Begley, D.J., L.K. Squires, B.V. Zlokovic, D.M. Mitrovic, C.C.W. Hugues, P.A. Revest and J. Greenwood, 1990, Permeability of the BBB to the immunosuppressive cyclic peptide cyclosporin A, J. Neurochem. 55, 1222.
5. Bodor, N., H.H. Farag and M.E. Brewster, 1981, Site-specific, sustained release of drugs to the brain, Science 214, 1370.
6. Bradford, M.M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
7. Brown, R.S. and R.L. Wahl, 1993, Overexpression of Glut-1 glucose transporter in human breast cancer, Cancer 72, 2979.
8. Cordon-Cardo, C., J.P. O'Brien, D. Casals, L. Rittman-Grauer, J.L. Biedler, M.R. Melamed and J. Bertino, 1989, Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites, Proc. Natl. Acad. Sci. USA 86, 695.
9. Dick, A.P.K., S.I. Harik and B.M. Walker, 1984, Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity, Proc. Natl. Acad. Sci. USA 81, 7233.
10. Feugeas, J.P., D. Neel, Y. Goussault and C. Derappe, 1991, Variabilité de l'activité biologique du transporteur du glucose dans les érythrocytes humains, C.R. Soc. Biol. 185, 190.
11. Greig, N.H., S. Momma, D.J. Sweeney, Q.R. Smithand and S.I. Rapoport, 1987, Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system, Cancer Res. 47, 1571.
12. Greig, N.H., T.T. Soncrant, U.H. Shetty, S. Momma, Q.R. Smith and S.I. Rapoport, 1990, Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat, Cancer Chemother. Pharmacol. 26, 263.
13. Hassner, A. and V. Alexanian, 1978, Direct room temperature esterification of carboxylic acids, Tetrahedron Lett. 4475.
14. Hatanaka, M., 1974, Transport of sugars in tumor cell membranes, Biochim. Biophys. Acta 355, 77.
15. Helgerson, A.L. and A. Carruthers, 1987, Equilibrium ligand binding to the human erythrocyte sugar transporter, J. Biol. Chem. 262, 5464.
16. Helgerson, A.L. and A. Carruthers, 1989, Analysis of protein-mediated 3-O-methylglucose transport in rat erythrocytes. Rejection of the alternating conformation carrier model for sugar transport, Biochemistry 28, 4580.
17. Hurst, D.T. and A.G. McInnes, 1965, The alcoholysis of trialkylalkoxy silanes. Part II. The preparation and chemistry of methyl 2,3,4-tri-O-trimethylsilyl-α-D-glucopyranoside, Can. J. Chem. 43, 2004.
18. Jarvis, S.M., 1988, Inhibition by nucleosides of glucose-transport activity in human erythrocytes, Biochem. J. 249, 383.
19. La Manna, J.C. and S.I. Harik, 1985, Regional comparisons of brain glucose influx, Brain Res. 326, 299.
20. Levin, U.A., 1980, Relationship of octanol-water partition coefficient and molecular weight to rat brain capillary permeability, J. Med. Chem. 23, 682.
21. Lowe, A.G. and A.R. Walmsley, 1986, The kinetics of glucose transport in human red blood cells, Biochim. Biophys. Acta 857, 146.
22. Malkin, M.G. and W.R. Shapiro, 1988, Brain tumors, Cancer Chemother. Biol. Resp. Modif. Ann. 10, 355.
23. Nishioka, T., Y. Oda, Y. Seino, T. Yamamoto, N. Inagaki, H. Yano, H.R. Shigemoto and H. Kikuchi, 1992, Distribution of the glucose transporters in human brain tumors, Cancer Res. 52, 3972.
24. Pardridge, W.M., 1983, Brain metabolism: a perspective from the blood-brain barrier, Physiol. Rev. 63, 1481.
25. Pardridge, W.M., 1988, Recent advances in blood-brain barrier transport, Annu. Rev. Pharmacol. Toxicol. 28, 25.
26. Pardridge, W.M., 1991, in: Peptide Drug Delivery to the Brain (Raven Press, New York, NY) 134.
27. Poll, R., F. Porreca, L.Z. Szabo, E.J. Bilsky, P. Davis, T.J. Abbruscato, T.P. Davis, R. Horvath, H.I. Yamamura and V.J. Hruby, 1994, Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier, Proc. Natl. Acad. Sci. USA 91, 7114.
28. Safa, A.R. and I. Tamai, 1990, Competitive interaction of cyclosporins with the vinca alcaloid-binding site of P-glycoprotein in multidrug resistant cells, J. Biol. Chem. 265, 16509.
29. Speizer, L., R. Haugland and H. Kutchai, 1985, Asymmetric transport of a fluorescent glucose analogue by human erythrocytes, Biochim. Biophys. Acta 815, 75.
30. Steck, T.L. and J.A. Kant, 1974, Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes, Methods Enzymol. 31, 172.
31. Still, W.C., M. Kahn and A. Mitra, 1978, Rapid Chromatographic technique for separations with moderate resolution, J. Org. Chem. 43, 2923.
32. Takada Y., D.T. Vistica, N.H. Greig, D. Purdon, S.I. Rapoport and Q.R. Smith, 1992, Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier, Cancer Res. 52, 2191.
33. Takada, Y., N.H. Greig, D.T. Vistica, S.I. Rapoport and Q.R. Smith, 1991, Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier, Cancer Chemother. Pharmacol. 29, 89.
34. Thomson, W., D. Nicholls, W.J. Irwin, S. Freeman, I. Walker and A. Karpas, 1992, Prodrugs of the phospho group for delivery to the CNS, International Symposium Drug Transport to the Brain, Abstracts, Noordwijkerhout.
35. Van Bree, J.B., A.G. De Boer, M. Danhof, L.A. Ginsel and D.D. Breimer, 1988, Characterization of an in vitro blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs, J. Pharmacol. Exp. Ther. 247, 1233.
36. Wheeler, T.J. and J.D. Whelan, 1988. Infinite-cis kinetics support the carrier model for erythrocyte glucose transport, Biochemistry 27, 1441.
37. Williams, S.A., T.J. Abbruscato, L. Szabo, V. Hruby and T.P. Davis, 1995, Does glycosylated DCDC-enkephalin use the GLUT-1 carrier to enter the CNS?, Cerebral Vascular Biology Conference, Abstract, July 10-12 1995, Paris.
38. Yamamoto, T., Y. Seino, H. Fukumoto, G. Koh, H. Yano, N. Inagaki, Y. Yamada, K. Inoue, T. Manbe and H. Imura, 1990, Over-expression of facilitative glucose transporter genes in human cancer, Biochem. Biophys. Res. Commun. 170, 223.